Search

everythinglearnresearchcommunity

for

Search:↓

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Wearing a hijab changes the common bacteria and fungi on the scalp, possibly affecting skin health.

Lifestyle changes like diet and exercise are crucial for managing PCOS.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Low levels of zinc, ferritin, and vitamin B12 are linked to severe hair loss in pregnant women during their last two trimesters.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Overweight women with PCOS are more likely to have excess male hormones.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Vietnamese women with PCOS tend to be younger, have larger waists, higher AMH levels, and more body hair than those without PCOS.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.